系统性创面管理在儿童Stevens-Johnson综合征/中毒性表皮坏死松解症治疗中的意义探讨

doi:10.35541/cjd.20210881

中华皮肤科杂志 ›› 2023, Vol. 56 ›› Issue (10): 940-942.doi: 10.35541/cjd.20210881

系统性创面管理在儿童Stevens-Johnson综合征/中毒性表皮坏死松解症治疗中的意义探讨

王莹陈立新毕田田李钦峰廉佳

天津市儿童医院皮肤科，天津 300074

收稿日期:2021-12-06 修回日期:2022-01-09 发布日期:2023-10-08
通讯作者: 廉佳 E-mail:78647133@qq.com
基金资助:
天津市卫生健康委员会科技项目（RC20125）

Role of systematic wound management in the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis in children

Wang Ying, Chen Lixin, Bi Tiantian, Li Qinfeng, Lian Jia

Department of Dermatology, Tianjin Children′s Hospital, Tianjin 300074, China

Received:2021-12-06 Revised:2022-01-09 Published:2023-10-08
Contact: Lian Jia E-mail:78647133@qq.com
Supported by:
Science and Technology Project of Tianjin Municipal Health Commission （RC20125）

摘要/Abstract

摘要： 【摘要】目的探讨系统性创面管理在儿童Stevens-Johnson综合征/中毒性表皮坏死松解症（SJS/TEN）治疗中的意义。方法回顾性分析2019年10月至2021年8月天津市儿童医院皮肤科收治的5例SJS/TEN患儿在药物治疗基础上，加强对皮肤和黏膜损伤系统性创面管理的作用。结果 5例2 ~ 13岁患儿（1例SJS，1例SJS/TEN重叠征，3例TEN）经甲泼尼龙静脉输注治疗和系统性创面管理后均治愈出院。入院时患儿TEN严重度评分为（18.6 ± 1.9）分，住院第7、10、14天分别为（13.8 ± 1.9）、（4.4 ± 0.5）、（2.0 ± 0.7）分，完成上皮化时间（10 ± 2.1） d，住院时间（14.4 ± 4.16） d；多学科随访4个月，均未见明显瘢痕，眼、口腔、生殖器、肺等黏膜部位未出现并发症。结论系统性创面管理有利于快速控制SJS/TEN病情，缩短创面愈合时间，改善患儿生活质量。

关键词: 儿童, Stevens-Johnson综合征, 创面管理, 治疗

Abstract: 【Abstract】 Objective To explore the role of systematic wound management in the treatment of Stevens-Johnson syndrome （SJS）/toxic epidermal necrolysis （TEN） in children. Methods Clinical data were collected from 5 children with SJS/TEN, who were admitted to the Department of Dermatology, Tianjin Children′s Hospital from October 2019 to August 2021, and retrospectively analyzed to investigate the role of systematic management of the skin and mucosa wound besides drug therapy in the treatment of SJS/TEN. Results The 5 patients, including 1 case of SJS, 1 case of SJS/TEN overlap syndrome, and 3 cases of TEN, were aged 2 to 13 years, and were cured and discharged after the treatment with intravenous methylprednisolone and systematic wound management. Among the 5 children, the severity of TEN scores （STENS） were 18.6 ± 1.9 points at admission, and 13.8 ± 1.9, 4.4 ± 0.5, and 2.0 ± 0.7 points on days 7, 10, and 14 during hospitalization, respectively; the time to complete re-epithelialization was 10 ± 2.1 days, and the length of hospital stay was 14.4 ± 4.16 days. During 4-month multidisciplinary follow-up, no scars or complications of the eyes, mouth, genitalia, or lungs occurred. Conclusion Systematic wound management is helpful to control the progress of SJS/TEN, accelerate wound healing, and improve patients′ quality of life.

Key words: Child, Stevens-Johnson syndrome, Wound management, Treatment

王莹陈立新毕田田李钦峰廉佳. 系统性创面管理在儿童Stevens-Johnson综合征/中毒性表皮坏死松解症治疗中的意义探讨[J]. 中华皮肤科杂志, 2023,56(10):940-942. doi:10.35541/cjd.20210881

Wang Ying, Chen Lixin, Bi Tiantian, Li Qinfeng, Lian Jia. Role of systematic wound management in the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis in children[J]. Chinese Journal of Dermatology, 2023, 56(10): 940-942.doi:10.35541/cjd.20210881

参考文献 15

［1］	中华医学会皮肤性病学分会药物不良反应研究中心. Stevens⁃Johnson综合征/中毒性表皮坏死松解症诊疗专家共识［J］. 中华皮肤科杂志, 2021,54（5）:376⁃381. doi: 10.35541/cjd.2020 1177.
［2］	Lee HY, Walsh SA, Creamer D. Long⁃term complications of Stevens⁃Johnson syndrome/toxic epidermal necrolysis （SJS/TEN）: the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow⁃up［J］. Br J Dermatol, 2017,177（4）:924⁃935. doi: 10.1111/bjd.15 360.
［3］	Aihara M, Kano Y, Fujita H, et al. Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens⁃Johnson syndrome and toxic epidermal necrolysis［J］. J Dermatol, 2015,42（8）:768⁃777. doi: 10.1111/1346⁃8138.12925.
［4］	韩锋, 张静静, 侯彦丽, 等. 单纯单次血浆置换疗法治疗17例中毒性表皮坏死松解症临床观察［J］. 中华皮肤科杂志, 2018,51（12）:896⁃898. doi: 10.3760/cma.j.issn.0412⁃4030.2018.12.010.
［5］	Yin B, Vinturache A, Zhang Y, et al. Toxic epidermal necrolysis in a child［J］. J Allergy Clin Immunol Pract, 2020,8（5）:1712⁃1713. doi: 10.1016/j.jaip.2020.01.018.
［6］	McPherson T, Exton LS, Biswas S, et al. British Association of Dermatologists′ guidelines for the management of Stevens⁃Johnson syndrome/toxic epidermal necrolysis in children and young people, 2018［J］. Br J Dermatol, 2019,181（1）:37⁃54. doi: 10.1111/bjd.17841.
［7］	Shi T, Chen H, Huang L, et al. Fatal pediatric Stevens⁃Johnson syndrome/toxic epidermal necrolysis: three case reports［J］. Medicine （Baltimore）, 2020,99（12）:e19431. doi: 10.1097/MD. 0000000000019431.
［8］	Techasatian L, Panombualert S, Uppala R, et al. Drug⁃induced Stevens⁃Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital［J］. World J Pediatr, 2017,13（3）:255⁃260. doi: 10.1007/s12519⁃016⁃0057⁃3.
［9］	Tocco⁃Tussardi I, Huss F, Presman B. Microbiological findings and antibacterial therapy in Stevens⁃Johnson syndrome/toxic epidermal necrolysis patients from a Swedish burn center［J］. J Cutan Pathol, 2017,44（5）:420⁃432. doi: 10.1111/cup.12894.
［10］	Schneider JA, Cohen PR. Stevens⁃Johnson syndrome and toxic epidermal necrolysis: a concise review with a comprehensive summary of therapeutic interventions emphasizing supportive measures［J］. Adv Ther, 2017,34（6）:1235⁃1244. doi: 10.1007/s12325⁃017⁃0530⁃y.
［11］	Lee HY. Wound management strategies in Stevens⁃Johnson syndrome/toxic epidermal necrolysis: an unmet need［J］. J Am Acad Dermatol, 2018,79（4）:e87⁃e88. doi: 10.1016/j.jaad.2018. 05.1258.
［12］	Rogers AD, Blackport E, Cartotto R. The use of Biobrane® for wound coverage in Stevens⁃Johnson syndrome and toxic epidermal necrolysis［J］. Burns, 2017,43（7）:1464⁃1472. doi: 10. 1016/j.burns.2017.03.016.
［13］	Houschyar KS, Tapking C, Borrelli MR, et al. Stevens⁃Johnson syndrome and toxic epidermal necrolysis: a 10⁃year experience in a burns unit［J］. J Wound Care, 2021,30（6）:492⁃496. doi: 10.12968/jowc.2021.30.6.492.
［14］	Chatproedprai S, Wutticharoenwong V, Tempark T, et al. Clinical features and treatment outcomes among children with Stevens⁃Johnson syndrome and toxic epidermal necrolysis: a 20⁃year study in a tertiary referral hospital［J］. Dermatol Res Pract, 2018,2018:3061084. doi: 10.1155/2018/3061084.
［15］	Duong TA, de Prost N, Ingen⁃Housz⁃Oro S, et al. Stevens⁃Johnson syndrome and toxic epidermal necrolysis: follow⁃up of pulmonary function after remission［J］. Br J Dermatol, 2015,172（2）:400⁃405. doi: 10.1111/bjd.13505.

[1]	孙小洁刘毅. 抗雄激素药物治疗皮肤病研究进展[J]. 中华皮肤科杂志, 2023, 56(9): 882-885.
[2]	王钰倩乔建军方红. 国内外斑秃诊疗指南/共识比较 [J]. 中华皮肤科杂志, 2023, 56(9): 885-888.
[3]	刘元香梁源赵欣荣孙玉娟马琳徐子刚. JAK抑制剂治疗儿童重症斑秃5例[J]. 中华皮肤科杂志, 2023, 56(9): 849-852.
[4]	王珊王星宇舒虹张斌石航杨欢钱秋芳马红艳梁源赵牧童申春平焦磊田晶汪洋谷盈孙婧刘盈李萍王华马琳. 克立硼罗软膏早期缓解儿童特应性皮炎临床症状及改善缓解期临床症状的多中心临床研究[J]. 中华皮肤科杂志, 2023, 56(9): 815-821.
[5]	申春平李萍罗晓燕梁源刘盈赵牧童王珊田晶焦磊汪洋罗珍余时娟方晓王华马琳. [开放获取] 某润肤霜联合周末外用糖皮质激素对延缓儿童特应性皮炎维持期疾病复发的随机、空白对照、多中心临床研究[J]. 中华皮肤科杂志, 2023, 56(8): 756-762.
[6]	袁心刚倪思利张建罗晓燕王华. 儿童黑素细胞痣的诊疗水平亟待提高[J]. 中华皮肤科杂志, 2023, 56(8): 782-786.
[7]	钟洁敏邵蕾梁毅敏黄琼霄夏曼琪刘玉梅. 射频火针与光动力疗法治疗面部中重度痤疮炎性皮损的疗效与安全性对比研究[J]. 中华皮肤科杂志, 2023, 56(8): 751-755.
[8]	宋志强陈奇权葛兰. 从特应性皮炎发病机制谈靶向治疗进展[J]. 中华皮肤科杂志, 2023, 56(8): 718-723.
[9]	王俊霞郭伟楠陈慧郝军峰李冰卫静宜赵涛. 自体脂肪移植治疗40例稳定期线状硬斑病疗效回顾分析[J]. 中华皮肤科杂志, 2023, 56(8): 762-765.
[10]	陈小敏张景展丁媛康晓静. 二甲双胍治疗银屑病的研究进展[J]. 中华皮肤科杂志, 2023, 56(8): 799-802.
[11]	周彤耿松梅. 生物制剂在大疱性类天疱疮治疗中的应用[J]. 中华皮肤科杂志, 2023, 56(8): 789-793.
[12]	李越吴金燕袁若月杨屈杨赵贤省朱宁文. 细胞治疗遗传性大疱性表皮松解症研究进展[J]. 中华皮肤科杂志, 2023, 56(7): 698-702.
[13]	孙蔺波徐教生. Curry-Jones综合征1例国内首报[J]. 中华皮肤科杂志, 2023, 56(7): 626-629.
[14]	中华医学会皮肤性病学分会银屑病专业委员会. 中国银屑病诊疗指南（2023版）[J]. 中华皮肤科杂志, 2023, 56(7): 573-625.
[15]	陈奇权杨显杰顾恒徐金华郝飞姚煦宋志强. [开放获取] 基于德尔菲法构建《中国慢性诱导性荨麻疹诊治专家共识（2023）》[J]. 中华皮肤科杂志, 2023, 56(6): 534-539.

系统性创面管理在儿童Stevens-Johnson综合征/中毒性表皮坏死松解症治疗中的意义探讨

Role of systematic wound management in the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis in children

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 15

相关文章 15

Metrics

本文评价

推荐阅读 10